PBH-T 1.17 ALA-T -0.05 WCP-T 0.04 SAP-T 0.19 CCA-T -0.41 TOI-X 4.88 BYD-T 2.44 CSU-T 136.84
Home Daily Stock Opinions and Ratings
Stockchase Opinions

Ed Ho Axcan Pharmaceuticals AXP-T STRONG BUY Dec 11, 2000

Products selling very well. Sales force based in US
Ed HoEd Ho
Unknown
Unlock Rating
$14.950

Stock price when the opinion was issued

biotechnology pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

DON'T BUY

Axcan Pharmaceuticals(AXP-T)

Jan 31, 2002
Had a nice run. May be a bit high now.
Malvin SpoonerMalvin Spooner
Unknown
Unlock Rating
$21.500

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Axcan Pharmaceuticals(AXP-T)

Jan 20, 2003
A good long term hold. They focus on their earnings. Well managed.
Pierre BernardPierre Bernard
Unknown
Unlock Rating
$17.850

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Axcan Pharmaceuticals(AXP-T)

May 20, 2003
Its OK earnings wise. They are trying to make a hostile take over which looks expensive. Core business is OK.
Glenn Paradis, BA, CFAGlenn Paradis, BA, CFA
Unknown
Unlock Rating
$16.930

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Axcan Pharmaceuticals(AXP-T)

Nov 03, 2003
The entire US financial sector is attractive. Their brokerage sector is growing rapidly. Expects travel business will pick up.
John Sinkins, CFAJohn Sinkins, CFA
Owned
Unlock Rating
$47.230

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Axcan Pharmaceuticals(AXP-T)

Nov 11, 2003
Has a very good ROE. Efficient balance sheet structure. Continuing to grow their earnings. Valuation is reasonable.
Peter Arender, CFAPeter Arender, CFA
Unknown
Unlock Rating
$17.400

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Axcan Pharmaceuticals(AXP-T)

Nov 09, 2004
Last news was that R&D spending would be higher than the street anticipated. Launching a product that could be a $200 million product.
Danny TomkaDanny Tomka
Owned
Unlock Rating
$19.500

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Axcan Pharmaceuticals(AXP-T)

Nov 24, 2004
A very focused (gastro intestinal) pharmaceutical company and as a result, it is very profitable. You pretty well get a free call option on a potentially block-buster drug called Itax. Huge market in North America.
Fred PynnFred Pynn
Owned
Unlock Rating
$20.980

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Axcan Pharmaceuticals(AXP-T)

Apr 14, 2005
Part pharmaceutical and part drug development. Very profitable. Strong balance sheet and lots of cash flow. Generates about US$1.50 free cash flow every year. In a very stable gastro-intestinal market. They're also in-licence some drugs which gives them some pretty good upside. Trading at about US$14 with $1 a share free cash on the balance sheet.
Chris FernycChris Fernyc
Owned
Unlock Rating
$18.600

Stock price when the opinion was issued

biotechnology pharmaceutical

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Latest Buy Signals

FTS-TFortis Inc.
Fortis Inc.
$66.72
0.61 (0.91%)
WCC-NWESCO International
WESCO International
$150.17
-12.22 (-8.86%)
T-TTelus Corp
Telus Corp
$20.08
0.04 (0.17%)
AQN-TAlgonquin Power & Utilities Corp
Algonquin Power & Utilities Corp
$7.34
-0.14 (-1.94%)
BIP.UN-TBrookfield Infrastructure Partners
Brookfield Infrastructure Partners
$41.27
-2.15 (-5.50%)
Advertising

Today's Top Picks

ALA-TAltagas Ltd
Altagas Ltd
$39.91
0.15 (0.37%)
PBH-TPremium Brands Holdings Corp
Premium Brands Holdings Corp
$78.52
1.17 (1.47%)
ARE-TAecon Group Inc
Aecon Group Inc
$17.46
0.52 (2.89%)
CSU-TConstellation Software Inc.
Constellation Software Inc.
$4,633.73
-106.27 (-2.35%)

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

DOO-TBRP Inc.
BRP Inc.
$49.56
-2.81 (-6.01%)
ABX-TBarrick Gold
Barrick Gold
$26.74
-1.04 (-4.05%)
WJX-TWajax Corp
Wajax Corp
$17.74
0.11 (0.62%)
AC-TAir Canada
Air Canada
$14.14
-0.20 (-1.43%)
WEN-QWendy's Company
Wendy's Company
$14.65
-0.07 (-0.48%)

Most Recent Experts

Stockchase

Stockchase Insights

5i Research

Teltscher

Rebecca Teltscher

Newhaven Asset Management

Omelchak

Andrey Omelchak

LionGuard Capital Management

Panic-Proof (Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Gems

The Monthly Gems by Allan Tong

Stockchase

Advertising
Advertising
© Stockchase Inc.